Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Combined exenatide and dapagliflozin has no additive effects on reduction of hepatocellular lipids despite better glycaemic control in patients with type 2 diabetes mellitus treated with metformin: EXENDA, a 24-week, prospective, randomized, placebo-controlled pilot trial
We'll match your condition to the right protocol, supply pharmaceutical-grade peptide and sterile injection kits, and walk you through every step from first injection to follow-up
With improved blood sugar control, individuals experience fewer diabetes-related symptoms and complications, leading to a better overall quality of life
High cost of GLP-1 drugs and affordability challenges hinder the market expansion
In the US, the age-adjusted death rate from cardiovascular disease has fallen about three-quarters since 1950
US$ 24.73
US$ 21.73
US$ 27.53
US$ 27.16
